| Renal hemodynamic effect of sodium-glucose co-transporter 2 inhibition in patients with type 1 diabetes mellitus DZ Cherney, BA Perkins, NCPA Soleymanlou, M Maione, V Lai, A Lee, ... Circulation 129 (5), 587-97, 2014 | 1416 | 2014 |
| Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus: cardiovascular and kidney effects, potential mechanisms, and clinical applications HJL Heerspink, BA Perkins, DH Fitchett, M Husain, DZI Cherney Circulation 134 (10), 752-772, 2016 | 1314 | 2016 |
| Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes RM Bergenstal, WV Tamborlane, A Ahmann, JB Buse, G Dailey, SN Davis, ... New England Journal of Medicine 363 (4), 311-320, 2010 | 1195 | 2010 |
| Regression of microalbuminuria in type 1 diabetes BA Perkins, LH Ficociello, KH Silva, DM Finkelstein, JH Warram, ... New England Journal of Medicine 348 (23), 2285-2293, 2003 | 1057 | 2003 |
| Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic … V Bril, J England, GM Franklin, M Backonja, J Cohen, D Del Toro, ... Pm&r 3 (4), 345-352. e21, 2011 | 944 | 2011 |
| Simple screening tests for peripheral neuropathy in the diabetes clinic BA Perkins, D Olaleye, B Zinman, V Bril Diabetes care 24 (2), 250-256, 2001 | 933 | 2001 |
| Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy V Bril, BA Perkins Diabetes care 25 (11), 2048-2052, 2002 | 583 | 2002 |
| Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management S Tesfaye, L Vileikyte, G Rayman, SH Sindrup, BA Perkins, M Baconja, ... Diabetes/metabolism research and reviews 27 (7), 629-638, 2011 | 558 | 2011 |
| The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus DZI Cherney, BA Perkins, N Soleymanlou, R Har, N Fagan, OE Johansen, ... Cardiovascular diabetology 13, 1-8, 2014 | 547 | 2014 |
| Association of vitamin D with insulin resistance and β-cell dysfunction in subjects at risk for type 2 diabetes S Kayaniyil, R Vieth, R Retnakaran, JA Knight, Y Qi, HC Gerstein, ... Diabetes care 33 (6), 1379-1381, 2010 | 519 | 2010 |
| Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials A Weisman, JW Bai, M Cardinez, CK Kramer, BA Perkins The lancet Diabetes & endocrinology 5 (7), 501-512, 2017 | 486 | 2017 |
| Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up … BA Perkins, RG Nelson, BEP Ostrander, KL Blouch, AS Krolewski, ... Journal of the American Society of Nephrology 16 (5), 1404-1412, 2005 | 480 | 2005 |
| Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes BA Perkins, LH Ficociello, BE Ostrander, KH Silva, J Weinberg, ... Journal of the American Society of Nephrology 18 (4), 1353-1361, 2007 | 476 | 2007 |
| Carpal tunnel syndrome in patients with diabetic polyneuropathy BA Perkins, D Olaleye, V Bril Diabetes Care 25 (3), 565-569, 2002 | 374 | 2002 |
| In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria BA Perkins, LH Ficociello, B Roshan, JH Warram, AS Krolewski Kidney international 77 (1), 57-64, 2010 | 364 | 2010 |
| Resistance versus aerobic exercise: acute effects on glycemia in type 1 diabetes JE Yardley, GP Kenny, BA Perkins, MC Riddell, N Balaa, J Malcolm, ... Diabetes care 36 (3), 537-542, 2013 | 362 | 2013 |
| Empagliflozin as adjunctive to insulin therapy in type 1 diabetes: the EASE trials J Rosenstock, J Marquard, LM Laffel, D Neubacher, S Kaspers, ... Diabetes care 41 (12), 2560-2569, 2018 | 340 | 2018 |
| Effects of performing resistance exercise before versus after aerobic exercise on glycemia in type 1 diabetes JE Yardley, GP Kenny, BA Perkins, MC Riddell, J Malcolm, P Boulay, ... Diabetes care 35 (4), 669-675, 2012 | 304 | 2012 |
| Serum urate lowering with allopurinol and kidney function in type 1 diabetes A Doria, AT Galecki, C Spino, R Pop-Busui, DZ Cherney, I Lingvay, ... New England Journal of Medicine 382 (26), 2493-2503, 2020 | 302 | 2020 |
| Sodium-glucose cotransporter 2 inhibition and glycemic control in type 1 diabetes: results of an 8-week open-label proof-of-concept trial BA Perkins, DZI Cherney, H Partridge, N Soleymanlou, H Tschirhart, ... Diabetes care 37 (5), 1480-1483, 2014 | 284 | 2014 |
David Z. CherneyProfessor of Medicine, University of TorontoEmail verificata su uhn.ca